Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein
Open Access
- 15 February 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 107 (4), 1397-1404
- https://doi.org/10.1182/blood-2005-08-3452
Abstract
Circulating antiplasmin-cleaving enzyme (APCE) has a role in fibrinolysis and appears structurally similar to fibroblast activation protein (FAP), a cell-surface proteinase that promotes invasiveness of certain epithelial cancers. To explore this potential relationship, we performed comparative structure/function analyses of the 2 enzymes. APCE from human plasma and recombinant FAP (rFAP) exhibited identical pH optima of 7.5, extinction coefficients (atchmode documentclass[fleqn,10pt,legalpaper]{article} usepackage{amssymb} usepackage{amsfonts} usepackage{amsmath} pagestyle{empty} egin{document} ({in}_{280mathrm{nm}}^{1%}) end{document}) of 20.2 and 20.5, common sequences of tryptic peptides, and cross-reactivity with FAP antibody. APCE and rFAP are homodimers with monomeric subunits of 97 and 93 kDa. Only homodimers appear to have enzymatic activity, with essentially identical kinetics toward Met-α2-antiplasmin (Met-α2AP) and peptide substrates. APCE and rFAP cleave both Pro3-Leu4 and Pro12-Asn13 bonds of Met-α2AP, but relative kcat/Km values for Pro12-Asn13 are about 16-fold higher than for Pro3-Leu4. APCE and rFAP demonstrate higher kcat/Km values toward a peptide modeled on P4-P4′ sequence surrounding the Pro12-Asn13 primary cleavage site than for Z-Gly-Pro-AMC and Ala-Pro-AFC substrates. These data support APCE as a soluble derivative of FAP and Met-α2AP as its physiologic substrate. Conversion of Met-α2AP by membrane or soluble FAP to the more easily fibrin-incorporable form, Asn-α2AP, may increase plasmin inhibition within fibrin surrounding certain neoplasms and have an impact on growth and therapeutic susceptibility.
Keywords
This publication has 38 references indexed in Scilit:
- Structural and Kinetic Analysis of the Substrate Specificity of Human Fibroblast Activation Protein αPublished by Elsevier BV ,2005
- Fibroblast activation protein-α and dipeptidyl peptidase IV (CD26): Cell-surface proteases that activate cell signaling and are potential targets for cancer therapyDrug Resistance Updates, 2005
- One Site Mutation Disrupts Dimer Formation in Human DPP-IV ProteinsPublished by Elsevier BV ,2004
- Purification, identification and characterisation of seprase from bovine serumThe International Journal of Biochemistry & Cell Biology, 2004
- A novel plasma proteinase potentiates α2-antiplasmin inhibition of fibrin digestionBlood, 2004
- Seprase Promotes Rapid Tumor Growth and Increased Microvessel Density in a Mouse Model of Human Breast CancerCancer Research, 2004
- The Expression of a Type II Transmembrane Serine Protease (Seprase) in Human Gastric CarcinomaOncology, 2004
- Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomasInternational Journal of Cancer, 2001
- Identification of the 170-kDa Melanoma Membrane-bound Gelatinase (Seprase) as a Serine Integral Membrane ProteasePublished by Elsevier BV ,1997
- Different NH2-Terminal Form with 12 Additional Residues of α2-Plasmin Inhibitor from Human Plasma and Culture Media of HEP G2 CellsBiochemical and Biophysical Research Communications, 1994